Hoth Therapeutics, Inc.
HOTH
$0.882
$0.01331.53%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -1.02% | 19.26% | 24.13% | 27.50% | 28.72% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 449.73% | -31.27% | -31.66% | -33.52% | -90.11% |
| Change in Net Operating Assets | 183.14% | -197.89% | -190.03% | -190.71% | -182.00% |
| Cash from Operations | 17.39% | -1.21% | 7.54% | 16.60% | 9.15% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -58.09% | -67.46% | -31.68% | -83.85% | 89.09% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -58.09% | -67.61% | -32.07% | -83.90% | 87.50% |
| Foreign Exchange rate Adjustments | -181.54% | 198.51% | 176.05% | 69.19% | 32.29% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -178.69% | -231.54% | -931.87% | -182.26% | 235.74% |